OSLO, Norway--(BUSINESS WIRE)--NEC OncoImmunity AS (NOI) today announced a publication that describes a novel approach to type new HLA alleles and characterize the HLA of tumors to guide personalized ...

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...

CareDx CDNA recently announced the launch of AlloSeq Nano, a nanopore-based HLA (human leukocyte antigen) and ABO genotyping ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted de novo classification to the SeCore CDx HLA Sequencing System for use as a companion diagnostic ...

DUBLIN--(BUSINESS WIRE)--The "HLA Typing Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent), Application (Cancer Research, Infectious & Non Infectious Diseases, ...

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...

Ultrahigh resolution (UHR) HLA matching is reported to result in better outcomes following unrelated donor hematopoietic cell transplantation, improving survival and reducing post-transplant ...

Immunogenetics experts at The Children's Hospital of Philadelphia (CHOP) have developed a unique laboratory test to characterize the genes that encode HLA molecules. The test relies on faster, more ...

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=39129877 As of 2024, the key players operating in the global HLA typing market are ...